United States · FDA National Drug Code directory
Nasonex
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0113-1720_c0445832-19fe-47e3-8225-6ccd59e8db50
- Product NDC
- 0113-1720
- Form
- SPRAY, METERED
- Composition / generic term
- mometasone furoate
- Labeler
- L. Perrigo Company
- Marketing category
- NDA
- Marketing start / end (source format)
- 20220629
- Source listing expiry
- 20271231
Source-listed ingredients
- MOMETASONE FUROATE MONOHYDRATE — 50 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, SPRAY in 1 PACKAGE (0113-1720-01) / 30 SPRAY, METERED in 1 BOTTLE, SPRAY · 0113-1720-01
- 1 BOTTLE, SPRAY in 1 PACKAGE (0113-1720-02) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY · 0113-1720-02
- 1 BOTTLE, SPRAY in 1 PACKAGE (0113-1720-04) / 144 SPRAY, METERED in 1 BOTTLE, SPRAY · 0113-1720-04
- 2 BOTTLE, SPRAY in 1 PACKAGE (0113-1720-06) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY · 0113-1720-06
- 3 BOTTLE, SPRAY in 1 PACKAGE (0113-1720-07) / 144 SPRAY, METERED in 1 BOTTLE, SPRAY · 0113-1720-07
- 1 BOTTLE, SPRAY in 1 PACKAGE (0113-1720-11) / 60 SPRAY, METERED in 1 BOTTLE, SPRAY · 0113-1720-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →